MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.
Identifieur interne : 000D07 ( Main/Exploration ); précédent : 000D06; suivant : 000D08MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.
Auteurs : Sacha I. Rothschild [Suisse] ; Oliver Gautschi [Suisse] ; Jasmin Batliner [Suisse] ; Mathias Gugger [Suisse] ; Martin F. Fey [Suisse] ; Mario P. Tschan [Suisse]Source :
- Lung cancer (Amsterdam, Netherlands) [ 1872-8332 ] ; 2017.
Descripteurs français
- KwdFr :
- Adénocarcinome (anatomopathologie), Adénocarcinome (génétique), Adénocarcinome (traitement médicamenteux), Autophagie (), Benzodioxoles (pharmacologie), Carcinome pulmonaire non à petites cellules (anatomopathologie), Carcinome pulmonaire non à petites cellules (génétique), Carcinome pulmonaire non à petites cellules (traitement médicamenteux), Dasatinib (pharmacologie), Homologue de la protéine-1 associée à l'autophagie (génétique), Humains, Inhibiteurs de protéines kinases (pharmacologie), Mouvement cellulaire (), Petit ARN interférent, Poumon (anatomopathologie), Protéines associées aux microtubules, Protéines et peptides de signalisation intracellulaire (génétique), Quinazolines (pharmacologie), Régulation négative (), Survie cellulaire (), Transduction du signal (), Tumeurs du poumon (anatomopathologie), Tumeurs du poumon (génétique), Tumeurs du poumon (traitement médicamenteux), microARN (génétique), src-Family kinases (antagonistes et inhibiteurs), src-Family kinases (métabolisme), src-Family kinases (pharmacologie).
- MESH :
- anatomopathologie : Adénocarcinome, Carcinome pulmonaire non à petites cellules, Poumon, Tumeurs du poumon.
- antagonistes et inhibiteurs : src-Family kinases.
- génétique : Adénocarcinome, Carcinome pulmonaire non à petites cellules, Homologue de la protéine-1 associée à l'autophagie, Protéines et peptides de signalisation intracellulaire, Tumeurs du poumon, microARN.
- métabolisme : src-Family kinases.
- pharmacologie : Benzodioxoles, Dasatinib, Inhibiteurs de protéines kinases, Quinazolines, src-Family kinases.
- traitement médicamenteux : Adénocarcinome, Carcinome pulmonaire non à petites cellules, Tumeurs du poumon.
- Autophagie, Humains, Mouvement cellulaire, Petit ARN interférent, Protéines associées aux microtubules, Régulation négative, Survie cellulaire, Transduction du signal.
English descriptors
- KwdEn :
- Adenocarcinoma (drug therapy), Adenocarcinoma (genetics), Adenocarcinoma (pathology), Adenocarcinoma of Lung, Autophagy (drug effects), Autophagy-Related Protein-1 Homolog (genetics), Benzodioxoles (pharmacology), Carcinoma, Non-Small-Cell Lung (drug therapy), Carcinoma, Non-Small-Cell Lung (genetics), Carcinoma, Non-Small-Cell Lung (pathology), Cell Movement (drug effects), Cell Survival (drug effects), Dasatinib (pharmacology), Down-Regulation (drug effects), Humans, Intracellular Signaling Peptides and Proteins (genetics), Lung (pathology), Lung Neoplasms (drug therapy), Lung Neoplasms (genetics), Lung Neoplasms (pathology), MicroRNAs (genetics), Microtubule-Associated Proteins, Protein Kinase Inhibitors (pharmacology), Quinazolines (pharmacology), RNA, Small Interfering, Signal Transduction (drug effects), src-Family Kinases (antagonists & inhibitors), src-Family Kinases (metabolism), src-Family Kinases (pharmacology).
- MESH :
- chemical , antagonists & inhibitors : src-Family Kinases.
- chemical , genetics : Autophagy-Related Protein-1 Homolog, Intracellular Signaling Peptides and Proteins, MicroRNAs.
- drug effects : Autophagy, Cell Movement, Cell Survival, Down-Regulation, Signal Transduction.
- drug therapy : Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms.
- genetics : Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms.
- chemical , metabolism : src-Family Kinases.
- pathology : Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung, Lung Neoplasms.
- chemical , pharmacology : Benzodioxoles, Dasatinib, Protein Kinase Inhibitors, Quinazolines, src-Family Kinases.
- Adenocarcinoma of Lung, Humans, Microtubule-Associated Proteins, RNA, Small Interfering.
Abstract
Src tyrosine kinase inhibitors (TKIs) significantly inhibit cell migration and invasion in lung cancer cell lines with minor cytotoxic effects. In clinical trials, however, they show modest activity in combination with chemotherapeutic agents. Possible resistance mechanisms include the induction of cytoprotective autophagy upon Src inhibition. Autophagy is a cellular recycling process that allows cell survival in response to a variety of stress stimuli including responses to various treatments.
DOI: 10.1016/j.lungcan.2016.06.004
PubMed: 27372519
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000202
- to stream PubMed, to step Curation: 000202
- to stream PubMed, to step Checkpoint: 000158
- to stream Ncbi, to step Merge: 000348
- to stream Ncbi, to step Curation: 000348
- to stream Ncbi, to step Checkpoint: 000348
- to stream Main, to step Merge: 000D07
- to stream Main, to step Curation: 000D07
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.</title><author><name sortKey="Rothschild, Sacha I" sort="Rothschild, Sacha I" uniqKey="Rothschild S" first="Sacha I" last="Rothschild">Sacha I. Rothschild</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Department of Clinical Research, University of Bern, Bern, Switzerland; Department Internal Medicine, Medical Oncology, University Hospital Basel, Basel, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Department of Clinical Research, University of Bern, Bern, Switzerland; Department Internal Medicine, Medical Oncology, University Hospital Basel, Basel</wicri:regionArea><wicri:noRegion>Basel</wicri:noRegion></affiliation></author><author><name sortKey="Gautschi, Oliver" sort="Gautschi, Oliver" uniqKey="Gautschi O" first="Oliver" last="Gautschi">Oliver Gautschi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Medical Oncology, Cantonal Hospital, Luzern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Medical Oncology, Cantonal Hospital, Luzern</wicri:regionArea><wicri:noRegion>Luzern</wicri:noRegion></affiliation></author><author><name sortKey="Batliner, Jasmin" sort="Batliner, Jasmin" uniqKey="Batliner J" first="Jasmin" last="Batliner">Jasmin Batliner</name><affiliation wicri:level="4"><nlm:affiliation>Department of Clinical Research, University of Bern, Bern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Clinical Research, University of Bern, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName><orgName type="university">Université de Berne</orgName></affiliation></author><author><name sortKey="Gugger, Mathias" sort="Gugger, Mathias" uniqKey="Gugger M" first="Mathias" last="Gugger">Mathias Gugger</name><affiliation wicri:level="4"><nlm:affiliation>Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName><orgName type="university">Université de Berne</orgName></affiliation></author><author><name sortKey="Fey, Martin F" sort="Fey, Martin F" uniqKey="Fey M" first="Martin F" last="Fey">Martin F. Fey</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Department of Clinical Research, University of Bern, Bern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Department of Clinical Research, University of Bern, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName></affiliation></author><author><name sortKey="Tschan, Mario P" sort="Tschan, Mario P" uniqKey="Tschan M" first="Mario P" last="Tschan">Mario P. Tschan</name><affiliation wicri:level="4"><nlm:affiliation>Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland. Electronic address: mario.tschan@pathology.unibe.ch.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName><orgName type="university">Université de Berne</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27372519</idno><idno type="pmid">27372519</idno><idno type="doi">10.1016/j.lungcan.2016.06.004</idno><idno type="wicri:Area/PubMed/Corpus">000202</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000202</idno><idno type="wicri:Area/PubMed/Curation">000202</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000202</idno><idno type="wicri:Area/PubMed/Checkpoint">000158</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000158</idno><idno type="wicri:Area/Ncbi/Merge">000348</idno><idno type="wicri:Area/Ncbi/Curation">000348</idno><idno type="wicri:Area/Ncbi/Checkpoint">000348</idno><idno type="wicri:Area/Main/Merge">000D07</idno><idno type="wicri:Area/Main/Curation">000D07</idno><idno type="wicri:Area/Main/Exploration">000D07</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.</title><author><name sortKey="Rothschild, Sacha I" sort="Rothschild, Sacha I" uniqKey="Rothschild S" first="Sacha I" last="Rothschild">Sacha I. Rothschild</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Department of Clinical Research, University of Bern, Bern, Switzerland; Department Internal Medicine, Medical Oncology, University Hospital Basel, Basel, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Department of Clinical Research, University of Bern, Bern, Switzerland; Department Internal Medicine, Medical Oncology, University Hospital Basel, Basel</wicri:regionArea><wicri:noRegion>Basel</wicri:noRegion></affiliation></author><author><name sortKey="Gautschi, Oliver" sort="Gautschi, Oliver" uniqKey="Gautschi O" first="Oliver" last="Gautschi">Oliver Gautschi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Medical Oncology, Cantonal Hospital, Luzern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Medical Oncology, Cantonal Hospital, Luzern</wicri:regionArea><wicri:noRegion>Luzern</wicri:noRegion></affiliation></author><author><name sortKey="Batliner, Jasmin" sort="Batliner, Jasmin" uniqKey="Batliner J" first="Jasmin" last="Batliner">Jasmin Batliner</name><affiliation wicri:level="4"><nlm:affiliation>Department of Clinical Research, University of Bern, Bern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Clinical Research, University of Bern, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName><orgName type="university">Université de Berne</orgName></affiliation></author><author><name sortKey="Gugger, Mathias" sort="Gugger, Mathias" uniqKey="Gugger M" first="Mathias" last="Gugger">Mathias Gugger</name><affiliation wicri:level="4"><nlm:affiliation>Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName><orgName type="university">Université de Berne</orgName></affiliation></author><author><name sortKey="Fey, Martin F" sort="Fey, Martin F" uniqKey="Fey M" first="Martin F" last="Fey">Martin F. Fey</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Department of Clinical Research, University of Bern, Bern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland; Department of Clinical Research, University of Bern, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName></affiliation></author><author><name sortKey="Tschan, Mario P" sort="Tschan, Mario P" uniqKey="Tschan M" first="Mario P" last="Tschan">Mario P. Tschan</name><affiliation wicri:level="4"><nlm:affiliation>Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland. Electronic address: mario.tschan@pathology.unibe.ch.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName><orgName type="university">Université de Berne</orgName></affiliation></author></analytic><series><title level="j">Lung cancer (Amsterdam, Netherlands)</title><idno type="eISSN">1872-8332</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (drug therapy)</term><term>Adenocarcinoma (genetics)</term><term>Adenocarcinoma (pathology)</term><term>Adenocarcinoma of Lung</term><term>Autophagy (drug effects)</term><term>Autophagy-Related Protein-1 Homolog (genetics)</term><term>Benzodioxoles (pharmacology)</term><term>Carcinoma, Non-Small-Cell Lung (drug therapy)</term><term>Carcinoma, Non-Small-Cell Lung (genetics)</term><term>Carcinoma, Non-Small-Cell Lung (pathology)</term><term>Cell Movement (drug effects)</term><term>Cell Survival (drug effects)</term><term>Dasatinib (pharmacology)</term><term>Down-Regulation (drug effects)</term><term>Humans</term><term>Intracellular Signaling Peptides and Proteins (genetics)</term><term>Lung (pathology)</term><term>Lung Neoplasms (drug therapy)</term><term>Lung Neoplasms (genetics)</term><term>Lung Neoplasms (pathology)</term><term>MicroRNAs (genetics)</term><term>Microtubule-Associated Proteins</term><term>Protein Kinase Inhibitors (pharmacology)</term><term>Quinazolines (pharmacology)</term><term>RNA, Small Interfering</term><term>Signal Transduction (drug effects)</term><term>src-Family Kinases (antagonists & inhibitors)</term><term>src-Family Kinases (metabolism)</term><term>src-Family Kinases (pharmacology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adénocarcinome (anatomopathologie)</term><term>Adénocarcinome (génétique)</term><term>Adénocarcinome (traitement médicamenteux)</term><term>Autophagie ()</term><term>Benzodioxoles (pharmacologie)</term><term>Carcinome pulmonaire non à petites cellules (anatomopathologie)</term><term>Carcinome pulmonaire non à petites cellules (génétique)</term><term>Carcinome pulmonaire non à petites cellules (traitement médicamenteux)</term><term>Dasatinib (pharmacologie)</term><term>Homologue de la protéine-1 associée à l'autophagie (génétique)</term><term>Humains</term><term>Inhibiteurs de protéines kinases (pharmacologie)</term><term>Mouvement cellulaire ()</term><term>Petit ARN interférent</term><term>Poumon (anatomopathologie)</term><term>Protéines associées aux microtubules</term><term>Protéines et peptides de signalisation intracellulaire (génétique)</term><term>Quinazolines (pharmacologie)</term><term>Régulation négative ()</term><term>Survie cellulaire ()</term><term>Transduction du signal ()</term><term>Tumeurs du poumon (anatomopathologie)</term><term>Tumeurs du poumon (génétique)</term><term>Tumeurs du poumon (traitement médicamenteux)</term><term>microARN (génétique)</term><term>src-Family kinases (antagonistes et inhibiteurs)</term><term>src-Family kinases (métabolisme)</term><term>src-Family kinases (pharmacologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>src-Family Kinases</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Autophagy-Related Protein-1 Homolog</term><term>Intracellular Signaling Peptides and Proteins</term><term>MicroRNAs</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome</term><term>Carcinome pulmonaire non à petites cellules</term><term>Poumon</term><term>Tumeurs du poumon</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>src-Family kinases</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Autophagy</term><term>Cell Movement</term><term>Cell Survival</term><term>Down-Regulation</term><term>Signal Transduction</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Non-Small-Cell Lung</term><term>Lung Neoplasms</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Non-Small-Cell Lung</term><term>Lung Neoplasms</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Adénocarcinome</term><term>Carcinome pulmonaire non à petites cellules</term><term>Homologue de la protéine-1 associée à l'autophagie</term><term>Protéines et peptides de signalisation intracellulaire</term><term>Tumeurs du poumon</term><term>microARN</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>src-Family Kinases</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>src-Family kinases</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Non-Small-Cell Lung</term><term>Lung</term><term>Lung Neoplasms</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Benzodioxoles</term><term>Dasatinib</term><term>Inhibiteurs de protéines kinases</term><term>Quinazolines</term><term>src-Family kinases</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Benzodioxoles</term><term>Dasatinib</term><term>Protein Kinase Inhibitors</term><term>Quinazolines</term><term>src-Family Kinases</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Adénocarcinome</term><term>Carcinome pulmonaire non à petites cellules</term><term>Tumeurs du poumon</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adenocarcinoma of Lung</term><term>Humans</term><term>Microtubule-Associated Proteins</term><term>RNA, Small Interfering</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Autophagie</term><term>Humains</term><term>Mouvement cellulaire</term><term>Petit ARN interférent</term><term>Protéines associées aux microtubules</term><term>Régulation négative</term><term>Survie cellulaire</term><term>Transduction du signal</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Src tyrosine kinase inhibitors (TKIs) significantly inhibit cell migration and invasion in lung cancer cell lines with minor cytotoxic effects. In clinical trials, however, they show modest activity in combination with chemotherapeutic agents. Possible resistance mechanisms include the induction of cytoprotective autophagy upon Src inhibition. Autophagy is a cellular recycling process that allows cell survival in response to a variety of stress stimuli including responses to various treatments.</div></front></TEI><affiliations><list><country><li>Suisse</li></country><region><li>Canton de Berne</li></region><settlement><li>Berne</li></settlement><orgName><li>Université de Berne</li></orgName></list><tree><country name="Suisse"><noRegion><name sortKey="Rothschild, Sacha I" sort="Rothschild, Sacha I" uniqKey="Rothschild S" first="Sacha I" last="Rothschild">Sacha I. Rothschild</name></noRegion><name sortKey="Batliner, Jasmin" sort="Batliner, Jasmin" uniqKey="Batliner J" first="Jasmin" last="Batliner">Jasmin Batliner</name><name sortKey="Fey, Martin F" sort="Fey, Martin F" uniqKey="Fey M" first="Martin F" last="Fey">Martin F. Fey</name><name sortKey="Gautschi, Oliver" sort="Gautschi, Oliver" uniqKey="Gautschi O" first="Oliver" last="Gautschi">Oliver Gautschi</name><name sortKey="Gugger, Mathias" sort="Gugger, Mathias" uniqKey="Gugger M" first="Mathias" last="Gugger">Mathias Gugger</name><name sortKey="Tschan, Mario P" sort="Tschan, Mario P" uniqKey="Tschan M" first="Mario P" last="Tschan">Mario P. Tschan</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D07 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D07 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27372519
|texte= MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27372519" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |